PMID: 18198474Jan 17, 2008Paper

Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy)

Journal of Pharmacological Sciences
Takayuki Nakagawa, Shuji Kaneko

Abstract

Psychostimulants including amphetamines and cocaine, opioids including morphine, and some recreational drugs share the ability to cause drug dependence and addiction. Although these drugs of abuse primarily act on distinct molecular targets, such as monoamine transporters or receptors, they finally converge to common neural pathways. Several lines of evidence suggest that their chronic treatment leads to the enhancement of the mesocorticolimbic dopaminergic neurons from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and the medial prefrontal cortex (mPFC) and leads to abnormal glutamatergic function from the mPFC to the NAc and VTA. The neural adaptation of dopaminergic-glutamatergic system is considered to be critically implicated in neuropsychotoxic effects of these drugs of abuse. In addition, recent studies suggest that the serotonergic neurons from the raphe nuclei to limbic areas modulate the mesocorticolimbic dopaminergic-glutamatergic system and participate in the neuropsychotoxicity. In this review, our recent in vitro studies on the molecular targets and neural adaptation of methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"), and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT, "foxy...Continue Reading

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·G Rudnick, S C Wall
Apr 1, 1991·Journal of Neuroscience Methods·L StoppiniD Muller
Apr 27, 1988·European Journal of Pharmacology·G BattagliaE B De Souza
Jul 1, 1994·Pharmacology, Biochemistry, and Behavior·T OhmoriT Koyama
Oct 4, 1993·Biochimica Et Biophysica Acta·G Rudnick, J Clark
Nov 1, 1996·Neuron·H A LesterS Mager
Dec 24, 1997·Brain Research. Brain Research Reviews·R C Pierce, P W Kalivas
Jun 6, 2003·Neuroscience and Biobehavioral Reviews·Jon C Cole, Harry R Sumnall
Jul 19, 2003·Pharmacological Reviews·A Richard GreenM Isabel Colado
Jan 11, 2005·Neurotoxicity Research·H G Baumgarten, L Lachenmayer
Nov 10, 2005·Journal of Neurochemistry·Analía BortolozziFrancesc Artigas
Jan 10, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joseph M BreierBryan K Yamamoto
Feb 8, 2006·Pharmacology, Biochemistry, and Behavior·W E FantegrossiJ H Woods
May 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lucas SalomonJean-Pol Tassin
Oct 19, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael T WilliamsCharles V Vorhees
Jan 16, 2007·European Journal of Pharmacology·Fumiko NagaiKanako Satoh Hisashi Kamimura
Feb 24, 2007·Progress in Neurobiology·Christian P MüllerMaria A De Souza Silva

❮ Previous
Next ❯

Citations

Oct 28, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kevin D LominacTod E Kippin
Oct 26, 2010·La Presse médicale·Laurent KarilaMichel Reynaud
Jul 21, 2010·Psychiatry Research·Yang-Tae KimYongmin Chang
Mar 17, 2010·Behavioural Brain Research·Ruth TellezAlfredo Meneses
Jun 23, 2010·British Journal of Clinical Pharmacology·Laurent KarilaSteven L Batki
Feb 1, 2011·Neuropharmacology·Alfredo MenesesCarlos Castillo
Jun 22, 2013·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Mohammad Reza EskandariHiman Heidari
May 17, 2013·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Hoyoung AnSeockhoon Chung
Jul 28, 2016·Neurotoxicity Research·Karolina Noworyta-SokołowskaKrystyna Gołembiowska
Dec 8, 2016·Journal of Addiction Medicine·Lara Grau-LópezCarlos Roncero
Jul 6, 2017·Drug Testing and Analysis·Katharina Elisabeth GrafingerWolfgang Weinmann
Jul 4, 2018·The American Journal on Addictions·Aparna DasJeffrey Clothier
Aug 4, 2009·Psychopharmacology·Ashwin A PatkarRima Kaddurah-Daouk
Aug 31, 2021·RSC Chemical Biology·Jinny Claire Lee, Kim D Janda
Apr 15, 2009·Current Opinion in Psychiatry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.